SCHEDULE 13G/A: Vanguard Group Discloses Significant Stake in Neogen Corp, Holding Over 10% of Common Stock

The Vanguard Group has filed an amended Schedule 13G, reporting a beneficial ownership of 10.85% in Neogen Corp's common stock as of March 31, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 23,550,128 shares of Neogen Corp common stock.
• This represents 10.85% of Neogen Corp's outstanding common stock.
• The filing is an Amendment No. 14 to Schedule 13G, indicating an update to a previously reported stake.
• The date of the event requiring this filing was March 31, 2025.
• Vanguard holds sole dispositive power over 23,177,556 shares and shared dispositive power over 372,572 shares.
• Vanguard holds sole voting power over 0 shares and shared voting power over 137,084 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Neogen Corp.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine disclosure of beneficial ownership and does not contain performance or strategic information that would indicate a positive or negative sentiment.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive positioning beyond indicating a significant investment by a major asset manager in the company.

Stakeholder Impact

• Shareholders may view the continued significant stake by a major institutional investor like The Vanguard Group as a sign of confidence in Neogen Corp's long-term prospects.

Key Dates

Keywords

Neogen Corp, Vanguard Group, Schedule 13G, beneficial ownership, common stock, institutional ownership, SEC filing, investment adviser